Indivior Pharmaceuticals, Inc. (INDV)
34.87
-0.43
(-1.22%)
USD |
NASDAQ |
Aug 28, 16:00
34.87
0.00 (0.00%)
After-Hours: 20:00
Indivior Pharmaceuticals Free Cash Flow : -119.51M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -119.51M |
| March 31, 2026 | -193.86M |
| December 31, 2025 | -94.86M |
| September 30, 2025 | 121.31M |
| June 30, 2025 | 179.35M |
| March 31, 2025 | 115.01M |
| December 31, 2024 | 5.015M |
| September 30, 2024 | -259.61M |
| June 30, 2024 | -262.14M |
| March 31, 2024 | -364.70M |
| December 31, 2023 | -366.70M |
| September 30, 2023 | -87.22M |
| June 30, 2023 | -25.82M |
| March 31, 2023 | 15.61M |
| December 31, 2022 | -17.39M |
| September 30, 2022 | 163.71M |
| June 30, 2022 | 134.74M |
| March 31, 2022 | 152.62M |
| December 31, 2021 | 316.62M |
| September 30, 2021 | 80.03M |
| June 30, 2021 | 80.40M |
| March 31, 2021 | 36.71M |
| Date | Value |
|---|---|
| December 31, 2020 | -198.29M |
| September 30, 2020 | -88.02M |
| June 30, 2020 | -76.10M |
| March 31, 2020 | -133.76M |
| December 31, 2019 | 145.24M |
| September 30, 2019 | 192.32M |
| June 30, 2019 | 255.19M |
| March 31, 2019 | 373.47M |
| December 31, 2018 | 258.47M |
| September 30, 2018 | 231.76M |
| June 30, 2018 | 155.79M |
| March 31, 2018 | 217.30M |
| December 31, 2017 | 251.30M |
| September 30, 2017 | 323.98M |
| June 30, 2017 | 400.50M |
| March 31, 2017 | 359.17M |
| December 31, 2016 | 400.17M |
| September 30, 2016 | 307.49M |
| June 30, 2016 | 253.88M |
| March 31, 2016 | 218.08M |
| December 31, 2015 | 290.08M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Supernus Pharmaceuticals, Inc. | 18.79M |
| Liquidia Corp. | 150.69M |
| Corcept Therapeutics, Inc. | 106.92M |
| Prestige Consumer Healthcare, Inc. | 235.36M |
| Harrow, Inc. | -13.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 228.52M |
| Cash from Investing (Quarterly) | -7.942M |
| Cash from Financing (Quarterly) | -172.64M |
| Free Cash Flow Per Share (Quarterly) | 1.787 |
| Free Cash Flow to Equity (Quarterly) | 221.58M |
| Free Cash Flow to Firm (Quarterly) | 223.11M |
| Free Cash Flow Yield | -2.70% |